Northeast Pharmaceutical Group Co., Ltd. Stock

Equities

000597

CNE0000009G0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
4.58 CNY -4.98% Intraday chart for Northeast Pharmaceutical Group Co., Ltd. -1.29% -14.39%

Financials

Sales 2022 8.81B 1.22B 1.66B Sales 2023 8.24B 1.14B 1.56B Capitalization 7.65B 1.06B 1.44B
Net income 2022 350M 48.3M 66.03M Net income 2023 358M 49.41M 67.54M EV / Sales 2022 0.84 x
Net cash position 2022 1.65B 227M 311M Net cash position 2023 3.47B 479M 654M EV / Sales 2023 0.51 x
P/E ratio 2022
25.2 x
P/E ratio 2023
21.4 x
Employees 6,214
Yield 2022
1.58%
Yield 2023
1.87%
Free-Float 41.71%
More Fundamentals * Assessed data
Dynamic Chart
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market MT
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman MT
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Northeast Pharma Appoints Former Bank Auditor as CFO MT
More news
1 day-4.98%
1 week-1.29%
Current month-3.98%
1 month-2.14%
3 months-5.37%
6 months-13.75%
Current year-14.39%
More quotes
1 week
4.54
Extreme 4.54
4.83
1 month
4.41
Extreme 4.41
5.04
Current year
3.77
Extreme 3.77
5.48
1 year
3.77
Extreme 3.77
6.00
3 years
3.77
Extreme 3.77
9.30
5 years
3.77
Extreme 3.77
9.30
10 years
2.88
Extreme 2.8828
9.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 05-04-30
Corporate Secretary 39 19-05-07
Members of the board TitleAgeSince
Director/Board Member 59 21-11-16
Chief Executive Officer 60 05-04-30
Director/Board Member 59 21-11-16
More insiders
Date Price Change Volume
24-04-26 4.58 -4.98% 33,919,550
24-04-25 4.82 +1.90% 11,983,540
24-04-24 4.73 +0.42% 7,584,470
24-04-23 4.71 +0.64% 8,210,008
24-04-22 4.68 +0.86% 9,271,217

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc. China accounts for 86.3% of net sales.
More about the company
  1. Stock Market
  2. Equities
  3. 000597 Stock